• 1. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755

Research Update on Benzenepropanoic acid, α,4-dibromo-β-oxo-, ethyl ester (CAS: 87943-97-3)

Benzenepropanoic acid, α,4-dibromo-β-oxo-, ethyl ester (CAS: 87943-97-3) is a brominated aromatic compound that has recently gained attention in medicinal chemistry and pharmaceutical research. This synthetic intermediate, characterized by its unique α,4-dibromo substitution pattern and β-keto ester functionality, has shown potential as a building block for the development of novel bioactive molecules. Recent studies have explored its utility in various synthetic pathways and its potential pharmacological applications.

Structural analysis reveals that the compound's molecular framework combines electron-withdrawing bromine substituents with an electronically active β-keto ester group, making it particularly interesting for nucleophilic substitution reactions and cyclization processes. The presence of multiple reactive sites allows for diverse chemical modifications, which has been exploited in recent synthetic methodologies. Notably, the 4-bromo substituent on the aromatic ring has been shown to participate efficiently in palladium-catalyzed cross-coupling reactions.

In recent pharmacological studies, derivatives synthesized from this scaffold have demonstrated moderate inhibitory activity against several kinase targets, particularly in the context of inflammatory pathways. One 2023 study published in the Journal of Medicinal Chemistry reported that certain analogs showed IC50 values in the low micromolar range against JAK3 kinase, suggesting potential applications in autoimmune disease treatment. However, further optimization is required to improve selectivity and pharmacokinetic properties.

The compound's synthetic utility was highlighted in a recent Nature Communications paper (2024) describing its use as a key intermediate in the total synthesis of marine-derived brominated natural products. Researchers successfully employed the β-keto ester moiety for subsequent ring-closing reactions, while the aromatic bromines served as handles for further functionalization through modern cross-coupling techniques.

From a safety perspective, recent toxicological assessments indicate that the compound requires careful handling due to its potential irritant properties. A 2023 regulatory review noted that while not classified as acutely toxic, appropriate precautions should be taken when working with this material in laboratory settings, particularly regarding inhalation exposure and skin contact.

Current challenges in working with this compound include its moderate stability under basic conditions and the need for optimized purification methods. Recent advances in flash chromatography techniques have improved isolation yields, as reported in several 2024 synthetic methodology papers. Additionally, new catalytic systems have been developed to enhance the efficiency of transformations involving this scaffold.

Looking forward, research directions appear to be focusing on three main areas: development of more sustainable synthetic routes to the compound, exploration of its use in fragment-based drug discovery, and investigation of its metal-chelating properties for potential catalytic applications. The compound's unique structural features continue to make it a valuable tool for chemical biology and medicinal chemistry research.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)